Position in EYPT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$118,638,162
+$11,697,889 QoQ
Shares Held
8,296,375
0.0% QoQ
Ownership
9.62%
of shares outstanding
% of Portfolio
2.57%
of 13F equity value
Holder Rank
#1
of 188 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,923,514,073 across 34 Biotechnology names. EYPT ranks #9 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MANE |
Veradermics, Inc
|
4,168,970 | $512,533,171 | |
| 2 | ARQT |
Arcutis Biotherapeutics, Inc.
|
12,437,000 | $326,098,140 | |
| 3 | LEGN |
Legend Biotech Corp
|
7,070,000 | $204,181,600 | |
| 4 | PVLA |
Palvella Therapeutics, Inc.
|
1,135,406 | $173,512,744 | |
| 5 | AVBP |
ArriVent BioPharma, Inc.
|
4,515,531 | $156,869,546 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
11,548,351 | $154,516,936 | |
| 7 | BHVN |
Biohaven Ltd.
|
10,286,937 | $153,069,622 | |
| 8 | RCUS |
Arcus Biosciences, Inc.
|
4,776,423 | $147,257,121 |
All Filings in EYPT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $118,638,162 | 8,296,375 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $106,940,273 | 8,296,375 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $143,011,804 | 7,827,685 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $88,184,261 | 6,192,715 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $64,026,496 | 6,804,091 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $36,878,173 | 6,804,091 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $50,534,027 | 6,783,091 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $41,354,825 | 5,175,823 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $45,029,660 | 5,175,823 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $77,799,564 | 3,763,888 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $93,753,734 | 4,056,847 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $27,902,254 | 3,492,147 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $29,787,903 | 3,423,897 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,980,997 | 3,394,897 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,717,639 | 3,347,897 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,577,752 | 3,233,597 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $23,359,789 | 2,968,207 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $35,349,295 | 2,909,407 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $30,841,128 | 2,519,700 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $17,761,817 | 1,704,589 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $12,391,204 | 1,378,332 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $12,000,992 | 1,181,200 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||